• News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Meg Monday

  • Study Finds New Treatment Improves Survival in Platinum-Resistant Ovarian Cancer
    April 26, 2026

    Study Finds New Treatment Improves Survival in Platinum-Resistant Ovarian Cancer

    Meg Monday
  • Daraxonrasib Shows Major Survival Benefit in Metastatic Pancreatic Cancer
    April 16, 2026

    Daraxonrasib Shows Major Survival Benefit in Metastatic Pancreatic Cancer

    Meg Monday
  • Mixing Up Your Exercise Routine May Help You Live Longer, Study Finds
    February 5, 2026

    Mixing Up Your Exercise Routine May Help You Live Longer, Study Finds

    Meg Monday
  • Blood Test May Help Predict Recurrence Risk for Early-Stage HR-Positive, HER2-Negative Breast Cancer
    December 14, 2025

    Blood Test May Help Predict Recurrence Risk for Early-Stage HR-Positive, HER2-Negative Breast Cancer

    Meg Monday
  • FDA Approves New Blood Test to Help Diagnose High-Grade Prostate Cancer
    December 8, 2025

    FDA Approves New Blood Test to Help Diagnose High-Grade Prostate Cancer

    Meg Monday
  • Trodelvy Shows Significant Benefit in Advanced Triple-Negative Breast Cancer
    October 22, 2025

    Trodelvy Shows Significant Benefit in Advanced Triple-Negative Breast Cancer

    Meg Monday
  • FDA Approves Libtayo to Help Prevent Return of High-Risk Skin Cancer After Surgery and Radiation
    October 20, 2025

    FDA Approves Libtayo to Help Prevent Return of High-Risk Skin Cancer After Surgery and Radiation

    Meg Monday
  • GLP-1 Drugs: A New Clue in Inflammation, Blood Cancer, and Cancer Risk
    October 20, 2025

    GLP-1 Drugs: A New Clue in Inflammation, Blood Cancer, and Cancer Risk

    Meg Monday
  • FDA Approves New Maintenance Treatment for Small Cell Lung Cancer
    October 4, 2025

    FDA Approves New Maintenance Treatment for Small Cell Lung Cancer

    Meg Monday
  • Blood Test Helps Detect Uterine Cancer Recurrence Earlier Than Scans
    September 30, 2025

    Blood Test Helps Detect Uterine Cancer Recurrence Earlier Than Scans

    Meg Monday
  • New Clinical Data for Daraxonrasib Sets Stage for Global Phase 3 Trial in Metastatic Pancreatic Cancer
    September 24, 2025

    New Clinical Data for Daraxonrasib Sets Stage for Global Phase 3 Trial in Metastatic Pancreatic Cancer

    Meg Monday
  • Early Blood Test Brings Hope for Detecting Pancreatic Cancer
    August 26, 2025

    Early Blood Test Brings Hope for Detecting Pancreatic Cancer

    Meg Monday
1 2
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
 

Loading Comments...